You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

albiglutide

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial in Boston (Albiglutide 50mg, Albiglutide matching , Exenatide 10microgram)

Terminated
Has Results
  • Diabetes Mellitus
  • Albiglutide 50mg
  • +3 more
  • Boston, Massachusetts
    GSK Investigational Site
Oct 8, 2020

Diabetes, Type 2 Trial in Louisville, Dallas (Exenatide, Albiglutide)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Louisville, Kentucky
  • +1 more
Oct 8, 2020

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Type 2 Diabetes Trial in Fresno (GLP1 receptor agonist, basal insulin, SGLT2 inhibitor)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • GLP1 receptor agonist
  • +3 more
  • Fresno, California
    UCSF Fresno
Oct 20, 2020

Diabetes, Type 1 Trial in Worldwide (Albiglutide weekly injection, Placebo weekly injection, Insulin)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Albiglutide weekly injection
  • +2 more
  • Bois-Guillaume, France
  • +31 more
Jun 12, 2020

Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Albiglutide
  • Insulin Glargine and Insulin Lispro
  • Searcy, Arkansas
  • +157 more
Nov 13, 2020

Diabetes, Type 2 Trial in United States (Lyophilized albiglutide DCC pen injector, Lyophilized albiglutide DCC pen injector

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lyophilized albiglutide DCC pen injector
  • +3 more
  • Birmingham, Alabama
  • +69 more
Jul 10, 2019

Diabetes, Type 2 Trial in United States (Albiglutide, Auto-injector)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Albiglutide
  • Auto-injector
  • Phoenix, Arizona
  • +26 more
Jul 11, 2019

Diabetes, Type 2 Trial in Chicago, Morehead City, El Paso (Albiglutide, Placebo)

Withdrawn
  • Diabetes Mellitus, Type 2
  • Albiglutide
  • Placebo
  • Chicago, Illinois
  • +2 more
Jan 16, 2019

Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide fixed ratio combination, liraglutide, exenatide)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Insulin glargine/lixisenatide fixed ratio combination
  • +6 more
  • Birmingham, Alabama
  • +123 more
Mar 15, 2022

Diabetes, Type 1, Endothelial Dysfunction Trial in Charlottesville (Dulaglutide, Placebo, exercise training)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Endothelial Dysfunction
  • Charlottesville, Virginia
    University of Virginia
Jul 25, 2022

GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

Completed
  • Type 2 Diabetes
  • Obesity
  • Valencia, Spain
    INCLIVA
Sep 6, 2022

Diabetes, Type 2 Trial in Baltimore (Albiglutide 50 mg, Placebo, CCK (Kinevac))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Albiglutide 50 mg
  • +2 more
  • Baltimore, Maryland
    GSK Investigational Site
Mar 9, 2018

Type 2 Diabetes Trial in Gurgaon (Degludec, Glargine U300)

Completed
  • Type 2 Diabetes
  • Gurgaon, Haryana, India
    Division Of Endocrinology and Diabetes , Medanta The Medicity Ho
Mar 3, 2022

Diabetes Trial in Worldwide (Albiglutide 30 mg, Albiglutide 50 mg, Albiglutide matching )

Completed
Has Results
  • Diabetes Mellitus
  • Albiglutide 30 mg
  • +2 more
  • Birmingham, Alabama
  • +607 more
Feb 11, 2019

Diabetes, Type 2 Trial in Brampton, Etobicoke, Toronto (Basal insulin glargine and lixisenatide, Basal insulin Basaglar/Lantus +

Completed
  • Diabetes Mellitus, Type 2
  • Basal insulin glargine and lixisenatide
  • +2 more
  • Brampton, Ontario, Canada
  • +2 more
Feb 24, 2021

Diabetes, Type 2 Trial in Austin (warfarin plus albiglutide)

Completed
  • Diabetes Mellitus, Type 2
  • warfarin plus albiglutide
  • Austin, Texas
    GSK Investigational Site
Jun 21, 2017

Diabetes, Type 2 Trial (Albiglutide, Moxifloxacin)

Completed
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jun 7, 2017

Diabetes, Type 2 Trial in Austin (simvastatin plus albiglutide)

Completed
  • Diabetes Mellitus, Type 2
  • simvastatin plus albiglutide
  • Austin, Texas
    GSK Investigational Site
Jun 7, 2017

Diabetes, Type 2 Trial in Austin (digoxin plus albiglutide)

Completed
  • Diabetes Mellitus, Type 2
  • digoxin plus albiglutide
  • Austin, Texas
    GSK Investigational Site
Jun 9, 2017

Diabetes, Type 2 Trial in South Africa, United States (albiglutide)

Completed
  • Diabetes Mellitus, Type 2
  • albiglutide
  • Anniston, Alabama
  • +6 more
Jul 18, 2017

Diabetes, Type 2 Trial in Austin (albiglutide, Oral contraceptive (Brevicon))

Completed
  • Diabetes Mellitus, Type 2
  • albiglutide
  • Oral contraceptive (Brevicon)
  • Austin, Texas
    GSK Investigational Site
Jun 13, 2017

Diabetes, Type 2 Trial in Chula Vista (albiglutide, )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • albiglutide
  • placebo
  • Chula Vista, California
    GSK Investigational Site
Nov 20, 2016

Diabetes, Type 2 Trial in Japan (albiglutide, )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • albiglutide
  • placebo
  • Aichi, Japan
  • +29 more
Nov 29, 2016

Diabetes, Type 2 Trial in Austin (Albiglutide Liquid Auto-injector, Albiglutide Lyophilized DCC Pen Injector, Placebo Liquid

Completed
  • Diabetes Mellitus, Type 2
  • Albiglutide Liquid Auto-injector
  • +3 more
  • Austin, Texas
    GSK Investigational Site
Nov 8, 2016